| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Wave Life Sciences Ltd. | Director | Ordinary Shares | 32.2K | $79.9K | $2.48 | Aug 12, 2024 | Direct |
| Nabriva Therapeutics plc | Director | Ordinary Shares | 7.2K | $10.8K | $1.50 | Aug 2, 2022 | Direct |
| Wave Life Sciences Ltd. | Director | Share Option (right to buy) | 64.5K | Aug 12, 2024 | Direct | ||
| TREVENA INC | Director | Stock Option (Right to Buy) | 13.7K | Jun 13, 2024 | Direct | ||
| TREVENA INC | Director | No securities beneficially owned | 0 | Jul 18, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| WVE | Wave Life Sciences Ltd. | Aug 12, 2024 | 2 | $0 | 4 | Aug 14, 2024 | Director |
| TRVN | TREVENA INC | Jun 13, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
| WVE | Wave Life Sciences Ltd. | Aug 7, 2023 | 1 | $0 | 4 | Aug 9, 2023 | Director |
| TRVN | TREVENA INC | Jul 18, 2023 | 1 | $0 | 4 | Jul 20, 2023 | Director |
| TRVN | TREVENA INC | Jul 18, 2023 | 0 | $0 | 3 | Jul 20, 2023 | Director |
| WVE | Wave Life Sciences Ltd. | Aug 15, 2022 | 1 | $0 | 4 | Aug 17, 2022 | Director |
| NBRV | Nabriva Therapeutics plc | Aug 2, 2022 | 1 | -$1.96K | 4 | Aug 4, 2022 | Director |
| WVE | Wave Life Sciences Ltd. | Aug 16, 2021 | 1 | $0 | 4 | Aug 18, 2021 | Director |
| NBRV | Nabriva Therapeutics plc | Jul 28, 2021 | 2 | $0 | 4 | Jul 30, 2021 | Director |
| NBRV | Nabriva Therapeutics plc | Jun 2, 2021 | 1 | $0 | 4 | Jun 4, 2021 | Director |
| NBRV | Nabriva Therapeutics plc | Jun 2, 2021 | 0 | $0 | 3 | Jun 4, 2021 | Director |